CSIMarket
 
Genetic Technologies Limited  (GENE)
 

company reported third quarter of 2019 operating loss of $0 millions


Published Nov 30 -0001
CSIMarket Team / CSIMarket.com


Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image8)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_CommonsFor the fiscal time-frame ending 0 company reached break-even of $0.00 per share compare to $0.00 a year before and from $0.00 per share from the previous reporting season.

Revenues remained unaltered to $0.00 millions from $0.00 millions in the comparable reporting season a year before and sequentially from $0.00 millions.




Genetic Technologies Limited reported unchanged a shortfall of $0.000 million, in the fiscal time-frame ending 0, from a year ago.


Genetic Technologies Limited is expected to report next financial earnings on August 29, 2023.



Genetic Technologies Limited's Executive Officers

Genetic Technologies Limited's Receivables Turnover Ratio



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com